Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

A UAB-developed automated online weight loss program helps cancer survivors achieve the highest weight loss ever reported for a digital intervention, improving cardiometabolic health, diet quality and ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

Because for most people, eating well isn’t hard in theory. It’s hard in the accumulation of choices. Breakfast, lunch, snacks ...

Moments after the ball drops on New Year’s Eve, people start talking about what they hope to accomplish in the new year — and weight loss is usually at the top of the list. It’s a common resolution, ...